Brian Di Donato

Brian joined Immunocore in April, 2020 from Achillion Pharmaceuticals, Inc., where he was Senior Vice President and Chief Financial Officer. Brian has more than 20 years of financial and leadership experience and leads Immunocore’s corporate strategy, finance, investor relations, competitive intelligence and information technology areas. Brian is an experienced capital markets banker, investor and fund manager, having held positions as Managing Director and Co-Portfolio Manager at Sorin Capital Management and President and Chief Investment Officer at Capmark Investments. He previously worked in fixed-income capital markets as an Executive Director at Morgan Stanley and Vice President at UBS Securities. Brian holds a Master of Business Administration from New York University’s Stern School of Business and bachelors of science degrees in biology from Penn State University and in mechanical engineering from Villanova University. Prior to business school, he was an aerospace engineering officer in the U.S. Navy.